EUVIMEDEUVIMED entdecken
Crossref

Imaging Modality and Outcomes in Patients with Skull Base Osteomyelitis

Nicholas A. Waring, Mickie Hamiter, Phillip Chung, Ana H Kim

Journal of Neurological Surgery Part B: Skull Base · 01.02.2024 · 85 (S 01 S 01) · S1-S398

DOI: 10.1055/s-0044-1779872 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.02.2024. Verfasst von Nicholas A. Waring und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Skull base osteomyelitis (SBO) secondary to otitis externa is a rare but highly morbid disease, and early diagnosis and treatment is important for improving outcomes. We investigated current practices in diagnostic imaging for SBO and treatment outcomes, along with other patient characteristics that may affect outcomes.

Methods

This retrospective cohort study identified all patients at our institution diagnosed with SBO from 01/01/2007 to 12/31/2022. The following data were collected for each patient: imaging modality and results, specialty requesting the imaging, diabetes and immunocompromise status, facial nerve involvement, and culture results. Outcome was defined as treatment duration > 8 weeks required. Fisher’s exact test was used for analysis.

Results

We identified 35 patients with SBO. Initial diagnosis was made with CT in 13/35 cases, MRI in 2/35 cases, CT and MRI in 9/35 cases, and a combination of CT, MRI, and/or nuclear medicine in 10/35 cases. PET was used in 2/35 cases. In 31 patients with data on treatment duration, 4/4 (100%) patients with aspergillus-positive SBO required treatment >8 weeks compared to 8/27 (29.6%) patients without aspergillus ( p = 0.0157). No significant associations with treatment duration were found for imaging modality, diabetes/immunocompromise status, or facial nerve involvement.

Conclusion

Despite recent literature recommending a shift towards PET/CT or PET/MRI to diagnose SBO, this has not carried over to current practice patterns at our institution, likely due to lack of awareness and cost. Imaging modality was not associated with treatment duration. Patients with aspergillus-positive SBO tend to require longer treatment. Publication History Article published online: 05 February 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Waring, N. A., Hamiter, M., Chung, P., & Kim, A. H. (2024). Imaging Modality and Outcomes in Patients with Skull Base Osteomyelitis. Journal of Neurological Surgery Part B: Skull Base, 85(S 01 S 01), S1-S398. https://doi.org/10.1055/s-0044-1779872

Vancouver

Waring NA, Hamiter M, Chung P, Kim AH. Imaging Modality and Outcomes in Patients with Skull Base Osteomyelitis. Journal of Neurological Surgery Part B: Skull Base. 2024;85(S 01 S 01):S1-S398. doi:10.1055/s-0044-1779872

BibTeX
@article{Waring2024,
  author = {Waring, Nicholas A. and Hamiter, Mickie and Chung, Phillip and Kim, Ana H},
  title = {Imaging Modality and Outcomes in Patients with Skull Base Osteomyelitis},
  journal = {Journal of Neurological Surgery Part B: Skull Base},
  year = {2024},
  volume = {85},
  number = {S 01 S 01},
  pages = {S1--S398},
  doi = {10.1055/s-0044-1779872}
}
Kostenlos starten →